Cargando…

Telemedicine and GM-2 gangliosidosis (Tay–Sachs) disease – A new savior on the horizon during COVID-19 pandemic

Detalles Bibliográficos
Autores principales:	Grover, Rohini, Sutar, Samir, Juneja, Supreet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Expedited Publication, Ophthalmic Image
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374826/ https://www.ncbi.nlm.nih.gov/pubmed/34146067 http://dx.doi.org/10.4103/ijo.IJO_681_21

Ejemplares similares

GM2-Gangliosidosis (Sandhoff and Tay Sachs disease): Diagnosis and Neuroimaging Findings (An Iranian Pediatric Case Series)
por: KARIMZADEH, Parvaneh, et al.
Publicado: (2014)

A feasibility study of mHealth and wearable technology in late onset GM2 gangliosidosis (Tay-Sachs and Sandhoff Disease)
por: Davies, Elin Haf, et al.
Publicado: (2020)

Enfermedad de Tay Sachs
por: Cibrián Cruz, José Alberto
Publicado: (1996)

Therapeutic Strategies For Tay-Sachs Disease
por: Picache, Jaqueline A., et al.
Publicado: (2022)

Lyso-GM2 Ganglioside: A Possible Biomarker of Tay-Sachs Disease and Sandhoff Disease
por: Kodama, Takashi, et al.
Publicado: (2011)

New Approaches to Tay-Sachs Disease Therapy
por: Solovyeva, Valeriya V., et al.
Publicado: (2018)

Wishbone Sign in GM1 Type III Gangliosidosis
por: Agarwal, Ayush, et al.
Publicado: (2023)

Characterization of Inducible Models of Tay-Sachs and Related Disease
por: Sargeant, Timothy J., et al.
Publicado: (2012)

Choroidal Coloboma in a Case of Tay-Sachs Disease
por: Ahmed, Nasreen Raees, et al.
Publicado: (2014)

Tay-Sachs disease: current perspectives from Australia
por: Lew, Raelia M, et al.
Publicado: (2015)

Prenatal diagnosis of Tay-Sachs disease: our institutional experience
por: Sheth, Jayesh, et al.
Publicado: (2014)

Neurodegeneration with Progressive Dystonia: Juvenile-Onset Tay–Sachs Disease
por: Kaur, Jasmine, et al.
Publicado: (2022)

Late-Onset Tay-Sachs Disease - expanding the clinical phenotype
por: Lefter, Stela, et al.
Publicado: (2023)

A novel gene editing system to treat both Tay-Sachs and Sandhoff diseases
por: Ou, Li, et al.
Publicado: (2020)

GM2 ganglioside accumulation causes neuroinflammation and behavioral alterations in a mouse model of early onset Tay-Sachs disease
por: Demir, Seçil Akyıldız, et al.
Publicado: (2020)

Expanding the spectrum of HEXA mutations in Indian patients with Tay–Sachs disease
por: Sheth, Jayesh, et al.
Publicado: (2014)

Cysts in White Matter: A Novel Neuroimaging Finding in Infantile GM1 Gangliosidosis
por: Kamate, Mahesh
Publicado: (2018)

Genetics and Therapies for GM2 Gangliosidosis
por: Cachón-González, María Begoña, et al.
Publicado: (2018)

GM1 Gangliosidosis: Mechanisms and Management
por: Rha, Allisandra K, et al.
Publicado: (2021)

Tay-Sachs' Disease: A Study of the Symptomatology and Pathology of Three Atypical Cases
por: Torrance, Herbert Watt
Publicado: (1922)

Tay-Sachs' Disease: A Study of the Symptomatology and Pathology of Three Atypical Cases
por: Torrance, Herbert Watt
Publicado: (1922)

Tay-Sachs' Disease: A Study of the Symptomatology and Pathology of Three Atypical Cases
por: Torrance, Herbert Watt
Publicado: (1922)

Neural stem cells for disease modeling and evaluation of therapeutics for Tay-Sachs disease
por: Vu, Mylinh, et al.
Publicado: (2018)

Autophagic flux is impaired in the brain tissue of Tay-Sachs disease mouse model
por: Sengul, Tugce, et al.
Publicado: (2023)

Nursing Care Plan for Patients with Tay–Sachs—A Rare Paediatric Disease
por: Cortés-Martín, Jonathan, et al.
Publicado: (2023)

Reworking protocols of ophthalmic resident surgical training in the COVID-19 era – Experiences of a tertiary care institute in northern India
por: Gupta, Parul Chawla, et al.
Publicado: (2021)

Knowledge and attitudes toward Tay-Sachs disease among a college student population.
por: Austein, C. F., et al.
Publicado: (1981)

Comparison of enzyme and DNA analysis in a Tay-Sachs disease carrier screening program.
por: Yoo, H. W., et al.
Publicado: (1993)

Efficient and precise generation of Tay–Sachs disease model in rabbit by prime editing system
por: Qian, Yuqiang, et al.
Publicado: (2021)

Letter response: Intra-familial phenotype variability in Late-Onset Tay-Sachs disease
por: Riboldi, Giulietta Maria, et al.
Publicado: (2023)

GM1 Gangliosidosis—A Mini-Review
por: Nicoli, Elena-Raluca, et al.
Publicado: (2021)

A Novel Hydrogen Sulfide Prodrug, SG1002, Promotes Hydrogen Sulfide and Nitric Oxide Bioavailability in Heart Failure Patients
por: Polhemus, David J., et al.
Publicado: (2015)

Identification of Novel Mutations in HEXA Gene in Children Affected with Tay Sachs Disease from India
por: Mistri, Mehul, et al.
Publicado: (2012)

Identification of novel mutations in HEXA gene in children affected with Tay-Sachs disease from India
por: Mistri, Mehul, et al.
Publicado: (2014)

Identification of deletion-duplication in HEXA gene in five children with Tay-Sachs disease from India
por: Sheth, Jayesh, et al.
Publicado: (2018)

Tay-Sachs Carrier Screening by Enzyme and Molecular Analyses in the New York City Minority Population
por: Mehta, Nikita, et al.
Publicado: (2016)

Patient and caregiver perspectives on burden of disease manifestations in late-onset Tay-Sachs and Sandhoff diseases
por: Lyn, Nicole, et al.
Publicado: (2020)

Novel HEXA variants in Korean children with Tay–Sachs disease with regression of neurodevelopment from infancy
por: Park, Ji Hong, et al.
Publicado: (2021)

GM1gangliosidosis: Clinical and radiological clue to diagnosis
por: Suthar, Renu, et al.
Publicado: (2012)

Animal models of GM2 gangliosidosis: utility and limitations
por: Lawson, Cheryl A, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hbq23k45f3e9icjdgubfrou892